Allergies in children

Paediatrics and Child Health

Volumn 6, Issue 8, 2001, Pages 555-566

  Chad, Zave ^a  

^a NONE   (Canada)

Author keywords

Allergic diseases; Allergies; Environmental factors

Indexed keywords

ADRENALIN; ALLERGEN; ANAKIT; ANTIALLERGIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; FOOD ALLERGEN; GLUCOCORTICOID; HYDROCORTISONE; IPRATROPIUM BROMIDE; IRRITANT AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; OXYGEN; PREDNISONE;

ALLERGIC RHINITIS; ALLERGY; ASTHMA; ATOPIC DERMATITIS; ATOPY; CHILD; CHILDHOOD DISEASE; ENVIRONMENTAL EXPOSURE; FOOD ALLERGY; GENETIC PREDISPOSITION; HUMAN; MORBIDITY; REVIEW; SENSITIZATION; SYMPTOMATOLOGY;

EID: 0035568127     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/6.8.555     Document Type: Review

References (96)

1. Environmental factors versus genetic determinants of childhood inhalants allergies
2. Lymphocyte control of in vivo immunoglobulin isotype selection
3. Evidence for compartmentalisation of functional subsets of CD4 + T-lymphocytes in atopic patients
4. Primary sensitization to inhalant allergens during infancy
5. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregancy a TH2 phenomenon?
6. Development of allergen specific memory in atopic and normal children
7. Reduced interferon-gamma production in infants with bronchiolitis and asthma
8. Cellular immunity is activated and a TH2 response is associated with early wheezing in infants after bronchiolitis
9. Prevention of chronic postbronchiolitis airway sequelae with IFN-gamma treatment in rats
10. Hay Fever, hygiene, and household size
11. The requirement of intestinal flora for the development of an IgE production system fully susceptible to oral tolerance induction
12. Antibiotic use during infancy promotes a shift in the TH1/TH2 balance towards a TH2-dominant immunity of mice
13. Absorption and malabsorption of dietary carbohydrates
14. Anaphylaxis
15. Biphasic and protracted anaphylaxis
16. Retrospective review of 89 patients with anaphylaxis
17. Basic mechanisms of anaphylaxis and anaphylactoid reactions
18. Fatal food induced anaphylaxis
19. Immediate hypersensitivity reactions to beta lactam antibiotics
20. Frequency of hymenoptera allergy in an atopic and normal population
21. Fatal and near fatal anaphylactic reactions to food in children and adolescent
22. Lessons for management of anaphylaxis from a study of fatal reactions
23. Cow's milk formula as a cause of infantile colic: A double-blind study
24. The Melbourne milk allergy study, 1976 to 1988
25. Predicting cow's milk allergy in children
26. Diagnostic features of atopic dermatitis
27. Atopic dermatitis
28. Atopic dermatitis: New insights and opportunities for therapeutic intervention
29. Decreased interferon gamma and increased interleukin 4 production in atopic dermatitis promotes IgE production
30. A twenty-one year follow-up of infantile eczema
31. Increased plasma histamine concentrations after food challenges in children with atopic dermatitis
32. Food hypersensitivity and atopic dermatitis: Evaluation of 113 patients
33. Increase in skin mast cells following chronic house dust mite exposure
34. Staphyloccocal colonization in atopic dermatitis and the effect of topical mupirocin therapy
35. Topical corticosteroids and S aureus in atopic dermatitis
36. Superantigens and their potential role in human disease
37. Evaluation of staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis
38. Cooperative double blind trial of an antibiotic/corticoid combination in impetiginized atopic dermatitis
39. The natural history of atopic eczema
40. Long term follow-up in atopic dermatitis
41. Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-86
42. Changes in asthma prevalence: Two surveys 15 years apart
43. Canadian asthma consensus report
44. Virus as precipitants of asthma symptoms. I. Epidemiology
45. Rhinovirus and influenza type A infections as precipitants of asthma
46. State of the art: Virus-induced airway hyperresponsiveness and asthma
47. The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years
48. Childhood asthma following hospitalization with acute viral bronchiolitis in infancy
49. Wheezing at age 8 and 13 years: Changing importance of bronchiolitis and passive smoking
50. Maternal smoking during pregnancy and lower respiratory tract illness in early life
51. The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy
52. Asthma and wheezing in the first six years of life
53. Social and familial factors in the development of early childhood asthma
54. Natural history of asthma in childhood - A birth cohort study
55. Relationship between atopy and bronchial hyperresponsiveness to histamine in a random population
56. Sensitivity to common allergens: Relation to respiratory symptoms and bronchial hyperresponsiveness in children from three different climatic areas of Australia
57. Increase in nonspecific bronchial responsiveness after repeated inhalation of low doses of allergen
58. The relative risks of sensitization to grass pollen, house dust mite and cat dander in the development of childhood asthma
59. Exposure to house dust mite allergen (DER p 1) and the development of asthma in childhood
60. A community-based study of the epidemiology of asthma. Incidence rates 1964-1983
61. Airway hyperresponsiveness in rhinitis, a risk factor for asthma
62. Airway responsiveness to cold air and hyperapnea in normal subjects and in those with hayfever and asthma
63. Seasonal variation of airway function in allergic rhinitis
64. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: Effect on lower airway responsiveness
65. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma
66. Relation of intranasal disease in the production of bronchial asthma
67. Incidence of asthma in 400 cases of chronic sinusitis
68. Studies in asthma: Nose and throat in 500 cases of asthma
69. Pathophysiology of reactive airways disease and sinusitis
70. The effect of nasal and nasopharyngeal irritation on airway resistance in man
71. Sinusitis and bronchial asthma
72. Improvement of bronchial hyperresponsiveness in asthmatic children treated for concomitant sinusitis
73. Predisposing factors for malocclusion in 7-year-old children with special reference to atopic diseases
74. Antihistamines and decongestants in the treatment of chronic rhinitis
75. Intranasal beclomethasone dipropionate in rhinitis
76. WHO position paper. Allergen immunotherapy: Therapeutic vaccines for allergic diseases
77. Lack of correlation between titers of serum allergen-specific IgE and symptoms in untreated patients with seasonal allergic rhinitis
78. Perinatal environmental factors influencing the development of allergy
79. Continuing increase in respiratory symptoms and atopy in Aberdeen Schoolchildren
80. IgE screening in 1701 newborn infants and the development of atopic disease during infancy
81. Comparison of cord blood immunoglobulin E concentration and maternal allergy for the prediction of atopic disease in infancy
82. IgE levels in cord blood and at age 4-5 days of age: Relation to clinical symptoms of atopic disease up to 18 months of age
83. Effect of combined maternal and infant food-allergen avoidance on the development of atopy in early infancy: A randomized study
84. Fetal peripheral blood mononuclear cell proliferative responses to mitogenic and allergenic stimuli during gestation
85. Social and familial factors in the development of early childhood asthma
86. Dust mites: Immunology, allergic disease and environmental control
87. Clinical evaluation of a double-blind dust avoidance trial with mite-allergic rhinitic patients
88. Environmental assay for cockroach allergens
89. Environmental exposure to cockroach allergens: Analysis with monoclonal-based enzyme immunoassays
90. Airborne concentrations and particle size distribution of allergen derived from domestic cats (Felis domesticus)
91. Airborne cat allergen (FEL D1): Environmental control with the cat in situ
92. Bioaerosols: Prevalence and health effects in the indoor environment
93. Parental smoking and respiratory illness in infancy
94. Involuntary smoking and the incidence of respiratory illness during the first year of life
95. Environmental control of indoor air pollution
96. Food allergy. Part 2: Diagnosis and management